JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 3


FIGURE 3. Analysis of 18F-labeled metabolites in arterial plasma. (A and B) Radiochromatograms obtained by isocratic-elution HPLC of acid-soluble extract from samples taken 90 min after intravenous injection of [18F]FU into a rat pretreated with eniluracil (A) and 60 min after intravenous injection of [18F]FU into a rat not pretreated with eniluracil (B). (C) UV absorbance chromatogram (wavelengths ≥ 254 nm) of an authentic sample of FU, which was obtained just before the radiochromatogram of (A). (D) UV absorbance chromatogram (wavelengths ≥ 214 nm) recorded simultaneously with radiochromatogram of (B). An aliquot of solution containing authentic, nonradiolabeled samples of {alpha}-fluoro-ß-alanine (FBAL), dihydrofluorouracil (FUH2), FU, fluorouridine (FUrd), and fluorodeoxyuridine (FdUrd) was added to the injectate in the run depicted in (B and D). Radiochromatogram for 18F-labeled fluoride ion ([18F]F) (dashed lines in D) was determined separately. Percentages of recovered radiolabel associated with various peaks are shown in (A and B).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE